I'm still rejecting the offer. I'm a long term holder for this one so do the math on that loss. I'd rather lose whats left than accept this crap opportunism.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%